SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

JMP Securities Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $7

JMP Securities maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and lowers the price target from $9 to $7.

Benzinga · -

JMP Securities maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and lowers the price target from $9 to $7.